<< Zimmer Holdings showcases Continuum Acetabular Cup System at AAOS 2010 | Confident Democrats predict House passes health bill this week >>

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Ελληνικά | Русский | Svenska | Polski

Report analyzes worldwide markets for Chronic Obstructive Pulmonary Disease

Published on March 12, 2010 at 11:28 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue:

Global Chronic Obstructive Pulmonary Disease Industry

http://www.reportlinker.com/p0181122/Global-Chronic-Obstructive-Pulmonary-Disease-Industry.html

This report analyzes the worldwide markets for Chronic Obstructive Pulmonary Disease in US$ Million. The report provides separate comprehensive analytics for US and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. The report profiles 53 companies including many key and niche players worldwide such as AstraZeneca Plc, Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, Novartis AG, Nycomed S.C.A. SICAR, Schering-Plough Corporation, Sepracor, Inc., and Vectura Group plc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SOURCE Reportlinker

35cbac09-98bb-4101-bf82-7cfd7797735e|0|.0

Posted in: Medical Condition News

Tags: Anti-Inflammatory, Asthma, Bronchitis, Corticosteroid, Drug Delivery, Emphysema, Pfizer, Smoking

Related posts

Forest Labs fourth quarter net sales increase 9.7% to $1,091.9 millionForest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announce...
Merck reports $342 million net income for 2010 third quarterMerck & Co., Inc. today announced financial results for the third quarter of 2010. The company repor...
Chelsea Therapeutics announces underwriters exercise 1.07 million additional shares to cover over-allotmentsChelsea Therapeutics International, Ltd. has completed its previously announced public offering of c...
Talecris Biotherapeutics announces 2010 eALTA award recipientsTalecris Biotherapeutics GmbH announced yesterday the recipients of the 2010 European alpha1-antitry...
Report on worldwide markets for cardiovascular drugsThis report analyzes the worldwide markets for Cardiovascular Drugs in US$ Million. Cardiovascular d...
Argentinean pharmaceutical market to reach $5.55bn in 2014Research and Markets (http://www.researchandmarkets.com/research/def8bb/argentina_pharmace) has anno...
Halozyme Therapeutics commences patient dosing in Phase 3 Enhanze trial with HerceptinHalozyme Therapeutics, Inc. and Roche today announced dosing of the first patient in a Phase 3 regis...
Pfizer to acquire Coley Pharmaceutical GroupPfizer has announced that it has entered into an agreement to acquire Coley Pharmaceutical Group, a ...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.